The von Hippel–Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal

The inactivation of the von Hippel–Lindau (VHL) tumor suppressor gene predisposes affected individuals to the human VHL cancer syndrome and is associated with sporadic renal cell carcinomas (RCC) and brain hemangioblastomas. VHL-negative 786–0 RCC cells are tumorigenic in nude mice which is suppress...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Proc Natl Acad Sci U S A
Päätekijät:	Pause, Arnim, Lee, Stephen, Lonergan, Kim M., Klausner, Richard D.
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	National Academy of Sciences 1998
Aiheet:	Biological Sciences
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC18649/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9448273/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.95.3.993
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!